A L Mahar1,2, A El-Sedfy1, M Dixon1,3, M Siddiqui1, M Elmi1, A Ritter1, J Vasilevska-Ristovska4, Y Jeong1,2,5, L Helyer6, C Law3,5,7, B Zagorski5, N G Coburn3,5,7. 1. Department of Community Health Sciences, University of Manitoba, Winnipeg, MB. 2. Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, ON. 3. Department of Surgery, University of Toronto, Toronto, ON. 4. Hospital for Sick Children, Toronto, ON. 5. Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON. 6. Department of Surgery, Dalhousie University, Halifax, NS. 7. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON.
Abstract
Background: Gastrectomy with negative resection margins and adequate lymph node dissection is the cornerstone of curative treatment for gastric cancer (gc). However, gastrectomy is a complex and invasive operation with significant morbidity and mortality. Little is known about surgical practice patterns or short- and long-term outcomes in early-stage gc in Canada. Methods: We undertook a population-based retrospective cohort study of patients with gc diagnosed between 1 April 2005 and 31 March 2008. Chart review provided clinical and operative details such as disease stage, primary tumour location, surgical approach, operation, lymph nodes, and resection margins. Administrative data provided patient demographics, geography, and vital status. Variations in treatment and outcomes were compared for 14 local health integration networks. Descriptive statistics and log-rank tests were used to examine geographic variation. Results: We identified 722 patients with nonmetastatic resected gc. We documented significant provincial variation in case mix, including primary tumour location, stage at diagnosis, and tumour grade. Short-term surgical outcomes varied across the province. The percentage of patients with 15 or fewer lymph nodes removed and examined varied from 41.8% to 73.8% (p = 0.02), and the rate of positive surgical margins ranged from 15.2% to 50.0% (p = 0.002). The 30-day surgical mortality rates did not vary statistically significantly across the province (p = 0.13); however, rates ranged from 0% to 16.7%. Overall 5-year survival was 44% and ranged from 31% to 55% across the province. Conclusions: This cohort of patients with resected stages i-iii gc is the largest analyzed in Canada, providing important historical information about treatment outcomes. Understanding the causes of regional variation will support interventions aiming to improve gc operative outcomes in the cancer system.
Background: Gastrectomy with negative resection margins and adequate lymph node dissection is the cornerstone of curative treatment for gastric cancer (gc). However, gastrectomy is a complex and invasive operation with significant morbidity and mortality. Little is known about surgical practice patterns or short- and long-term outcomes in early-stage gc in Canada. Methods: We undertook a population-based retrospective cohort study of patients with gc diagnosed between 1 April 2005 and 31 March 2008. Chart review provided clinical and operative details such as disease stage, primary tumour location, surgical approach, operation, lymph nodes, and resection margins. Administrative data provided patient demographics, geography, and vital status. Variations in treatment and outcomes were compared for 14 local health integration networks. Descriptive statistics and log-rank tests were used to examine geographic variation. Results: We identified 722 patients with nonmetastatic resected gc. We documented significant provincial variation in case mix, including primary tumour location, stage at diagnosis, and tumour grade. Short-term surgical outcomes varied across the province. The percentage of patients with 15 or fewer lymph nodes removed and examined varied from 41.8% to 73.8% (p = 0.02), and the rate of positive surgical margins ranged from 15.2% to 50.0% (p = 0.002). The 30-day surgical mortality rates did not vary statistically significantly across the province (p = 0.13); however, rates ranged from 0% to 16.7%. Overall 5-year survival was 44% and ranged from 31% to 55% across the province. Conclusions: This cohort of patients with resected stages i-iii gc is the largest analyzed in Canada, providing important historical information about treatment outcomes. Understanding the causes of regional variation will support interventions aiming to improve gc operative outcomes in the cancer system.
Authors: Alia P Qureshi; C Andrea Ottensmeyer; Alyson L Mahar; Runjan Chetty; Aaron Pollett; Frances C Wright; Natalie G Coburn Journal: Ann Surg Oncol Date: 2009-05-07 Impact factor: 5.344
Authors: V E P P Lemmens; K Bosscha; G van der Schelling; S Brenninkmeijer; J W W Coebergh; I H J T de Hingh Journal: Br J Surg Date: 2011-06-29 Impact factor: 6.939
Authors: Waddah B Al-Refaie; Greer Gay; Beth A Virnig; Jennifer F Tseng; Andrew Stewart; Selwyn M Vickers; Todd M Tuttle; Barry W Feig Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: Jung Ho Shim; Kyo Young Song; Hae Myung Jeon; Cho Hyun Park; Lindsay M Jacks; Mithat Gonen; Manish A Shah; Murray F Brennan; Daniel G Coit; Vivian E Strong Journal: Ann Surg Oncol Date: 2014-03-06 Impact factor: 5.344
Authors: Radoslaw Jaworski; Elfriede Bollschweiler; Arnulf H Holscher; Stefan P Monig; Jaroslaw Skokowski; Jacek Zielinski; Maciej Swierblewski; Andrzej Kopacz; Janusz Jaskiewicz Journal: Gastric Cancer Date: 2011-03-26 Impact factor: 7.370
Authors: M W J M Wouters; H E Karim-Kos; S le Cessie; B P L Wijnhoven; L P S Stassen; W H Steup; H W Tilanus; R A E M Tollenaar Journal: Ann Surg Oncol Date: 2009-04-16 Impact factor: 5.344
Authors: Jordan Levy; Vaibhav Gupta; Elmira Amirazodi; Catherine Allen-Ayodabo; Naheed Jivraj; Yunni Jeong; Laura E Davis; Alyson L Mahar; Charles De Mestral; Olli Saarela; Natalie Coburn Journal: Gastric Cancer Date: 2019-11-04 Impact factor: 7.370